Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Itraconazole and Rifampicin on TPN171H PK in Healthy Subjects
NCT06090123Phase 1Completed
- Sponsor
- Vigonvita Life Sciences
- Start
- Jan 2020
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of sildenafil in erectile dysfunction (ED) (2 arms), sponsored by Vigonvita Life Sciences. Primary endpoints: Maximum Plasma Concentration (Cmax) of TPN171H at 48 hours and Area Under the Curve (AUC) of TPN171H at 48 hours. Started Jan 2020; status: completed.
02
Drugs
sildenafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT06090123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06090123.